GlaxoSmithKline PLC's ticker is and the CUSIP is G3910J112. A total of 5 filers reported holding GlaxoSmithKline PLC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $19,000 | -5.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $20,000 | +11.1% | 1,000 | 0.0% | 0.00% | – |
| Q1 2021 | $18,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2020 | $18,000 | -5.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $19,000 | -5.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $20,000 | +5.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $19,000 | -20.8% | 1,000 | 0.0% | 0.00% | – |
| Q4 2019 | $24,000 | +14.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $21,000 | +5.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $20,000 | -4.8% | 1,000 | 0.0% | 0.00% | – |
| Q1 2019 | $21,000 | +10.5% | 1,000 | 0.0% | 0.00% | – |
| Q4 2018 | $19,000 | -5.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $20,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2018 | $20,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2018 | $20,000 | +11.1% | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $18,000 | -10.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2017 | $20,000 | -4.8% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $21,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $21,000 | +10.5% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $19,000 | -9.5% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $21,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $21,000 | +5.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $20,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $20,000 | +5.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2015 | $19,000 | -9.5% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $21,000 | -8.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $23,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|